Acute Myocardial Infarction (AMI)
61
17
21
21
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 61 trials
100.0%
+13.5% vs benchmark
18%
11 trials in Phase 3/4
5%
1 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (61)
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction
A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital
Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction
Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Dexrazoxane to Protect Against Hemorrhagic STEMI
Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I
Ventricular Arrhythmias in Acute Myocardial Infarction
Relationship Between RAR and MACEs in AMI-CS Patients During Hospitalization
Artificial Intelligence Scalable Solution for ST Myocardial Infarction
Construction and Analysis of a Risk Prediction Model for Acute Myocardial Infarction Based on Spatiotemporal Heterogeneous Data
Prospective Lifespan Cohort of Myocardial Infarction
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
IABP for MI-VSD Patients in SCAI SHOCK Stage B
Fast Discharge After Acute Myocardial Infarction Discharge MI
Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction
Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II
Acute Myocardial Infarction - Allied Health-Oriented Patient-centered Digitally-Enabled Care
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock